Friday Pop Quiz 5/23/2025
What is the first-line therapy for the mild-moderate disease depicted in the image?
A. Narrow-band UVB
B. Biologic agents
C. Acitretin
D. Topical glucocorticoids
E. Methotrexate
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. …
What is the first-line therapy for the mild-moderate disease depicted in the image?
A. Narrow-band UVB
B. Biologic agents
C. Acitretin
D. Topical glucocorticoids
E. Methotrexate
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
*Brand partners had no involvement in the content of the questions or answers. … 
Triggering factors in this generalized variant of psoriasis include all of the following EXCEPT:
A. Pregnancy
B. Rapid tapering of sytemic therapies
C. Hypocalcemia
D. Infections
E. Topical irritants
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
Pentoxifylline is a methyl-xanthine derivative traditionally used to treat symptoms of peripheral vascular disease and has emerged as a valuable therapeutic agent in dermatology for its anti-inflammatory and immunomodulatory properties. We continue our series, Therapeutic Cheat Sheet, with a closer look at pentoxifylline, which is FDA-approved for the treatment of intermittent claudication and is … 
There’s a new moniker for facial puffiness: “cortisol face.” As described in an article in Parade, cortisol face is a catch-all term for facial swelling due to elevated cortisol levels. The term became popular on TikTok to describe facial puffiness, roundness, and redness or flushing. Physicians quoted in the article pointed out the benefits of cortisol and recommended people talk to their d … 
A 35-year-old woman presents to clinic with the skin lesions (shown) and joint pain. She was previously well controlled on guselkumab, but has flared since her dog was diagnosed with cancer. She has previously failed various treatments including topical steroids, methotrexate, narrow-band UVB, adalimumab, ixekizumab, and etanercept. She developed transaminitis and hepatic steatosis in response t … 